Drug lookup
Drug reference

safinamide

MAO-B Inhibitor · Parkinson's disease treatment

MAO-B InhibitorParkinson's disease treatment
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
incl. contraindicated
PREGNANCY
not curated
Top interactionssee all 12
  • MeperidineContraindicatedTextbookG&G 14e · p419, p424
  • AlfentanilSevereDatabaseDDInter
  • AmitriptylineSevereDatabaseDDInter
  • AmoxapineSevereDatabaseDDInter

Mechanism

Selectively inhibits monoamine oxidase B (MAO-B), which can increase dopamine (DA) levels.

Indications

Parkinson's diseaseAdjunctive therapy to levodopa for off periods in PD

Drug interactions

Meperidine
Contraindicated
Textbook

Stupor, rigidity, agitation, and hyperthermia.

Safinamide should not be given in combination with meperidine.

Source: G&G 14e · p419, p424

Alfentanil
Severe
Database

Drug interaction classified as: others

Source: DDInter

Amitriptyline
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amoxapine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amphetamine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Apraclonidine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Berotralstat
Severe
Database

Drug interaction classified as: absorption

Source: DDInter

Bupropion
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Buspirone
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Clomipramine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Cyclobenzaprine
Severe
Database

Clinical effect not specified

Source: DDInter

Desipramine
Severe
Database

Clinical effect not specified

Source: DDInter

Related guidelines

Ask House about safinamide

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team